Endothelial cells adhere to the RGD domain and the fibrinogen-like terminal knob of tenascin by unknown
INTRODUCTION
Tenascin (TN) is a large ECM protein prominent in
restricted embryonic tissues, healing wounds and tumors
(Erickson and Bourdon, 1989). Six elongated subunits are
linked by disulfides into a 2,000 kDa molecule called the
hexabrachion. Each arm of the hexabrachion is a tenascin
subunit, and comprises 14 domains homologous to epider-
mal growth factor (EGF), 8-15 FN-III domains, and a fib-
rinogen-like domain (Fig. 1). The third FN-III domain
(TNfn3) in human TN has an RGD on the loop connecting
beta strands F and G (Leahy et al., 1992), which is the same
location as the RGD in the fibronectin (FN) domain FNfn10
(Main et al., 1992). There has been considerable interest in
testing TN for cell adhesion activity, with controversial
results reported by several laboratories (reviewed by Erick-
son and Bourdon, 1989). 
More recently, attention has focused on possible anti-
adhesion activities of TN. Chiquet-Ehrismann et al. (1988)
reported that TN could inhibit adhesion of cells to a
fibronectin (FN) substratum. Lightner and Erickson (1990)
confirmed these observations and concluded that the mech-
anism was steric blocking of the substratum. The large
hexabrachion molecules bound to the plastic, straddling the
fibronectin molecules and efficiently covering up their cell
adhesion sites. 
Anti-adhesion mechanisms have been attributed to two
specific domains of TN. Murphy-Ulrich et al. (1991)
reported that the alternatively spliced segment of TN
(TNfnA-D in Fig. 1) caused a loss of focal contacts when
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We have found that endothelial cells adhere much more
strongly than fibroblasts to domains of tenascin and
fibronectin. Endothelial cells adhered weakly, without
spreading, to bacterial expression proteins correspond-
ing to the tenth fibronectin type III (FN-III) domain of
fibronectin, which contains the RGD. A larger
fibronectin protein, containing this domain and the
three amino-terminal ‘synergy’ domains gave strong
adhesion and spreading. Two widely separated domains
of tenascin gave adhesion. The third FN-III domain,
TNfn3, which contains an RGD sequence in human and
chicken tenascin, gave very strong adhesion and spread-
ing of endothelial cells when tested as an isolated
domain. Larger segments containing TNfn3 and the
adjacent TNfn2 gave weaker adhesion, probably
because the RGD sequence is partially blocked. Adhe-
sion to this domain required divalent cations, was
exquisitely sensitive to soluble GRGDSP peptide, and
was blocked by antisera to the integrin v 3. The second
tenascin adhesion domain was the fibrinogen-like C-ter-
minal knob, TNfbg. Cells adhered to but did not spread
on this domain. This adhesion required divalent cations
and was also sensitive to GRGDSP peptide, so it may
be mediated by an integrin receptor.
We have explored a range of conditions for prepar-
ing the adhesion substratum, and our results may
resolve the controversy over whether tenascin can act
as a substratum adhesion molecule. When coated for
short times (1-2 hours) on plastic, tenascin had no adhe-
sion activity, in contrast to fibronectin and the
expression proteins, which gave strong adhesion under
these conditions. When coated for longer times (12-24
hours) on plastic, the tenascin substratum supported
good adhesion, but not spreading, of endothelial cells.
Tenascin coated on nitrocellulose gave substantially
stronger adhesion than on plastic, but still required
long coating times for maximal activity. Adhesion of
endothelial cells to native TN was inhibited by
GRDGSP peptide. The cell adhesion activity demon-
strates the presence on endothelial cells of tenascin
receptors, which may play a supportive role in angio-
genesis, in the structure of blood vessels, or in binding
tenascin to the cell surface to elicit or enhance a sig-
nalling function. 
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added as a soluble protein to well-spread endothelial cells.
Chiquet et al. (1991) reported that a proteolytic fragment
comprising the last three FN-III repeats and the fibrinogen
domain (TNfn6-8 plus TNfbg) inhibited spreading of
fibroblasts on FN. Prieto et al. (1992) reported an anti-adhe-
sion effect of a fusion protein corresponding approximately
to TNfn7-8. Inhibition of adhesion and spreading was
observed when this fusion protein was incorporated as a
mixed substratum with FN, and also when pre-incubated
with cells. These last two reports both indicate an anti-adhe-
sion activity in TNfn7-8. 
To provide tools for extended studies of TN, we have
produced a library of bacterial and mammalian expression
proteins that map the entire hexabrachion arm in defined
segments (Aukhil et al., 1993; and Fig. 1). Each of the pro-
teins corresponds to precisely defined boundaries of the FN-
III domains and contains no fusion protein. The expression
proteins are all soluble as monomeric molecules, and each
has been highly purified. Of course these bacterial
expression proteins are not glycosylated, but the biochem-
ical analysis suggests that they are all correctly folded and
otherwise identical to the domains in native TN (Aukhil et
al., 1993). The set of bacterial proteins is complemented by
mammalian expression proteins HxB.L, HxB.S and
HxB.egf, corresponding to the large and small splice vari-
ants of human tenascin, and to a protein truncated at the
end of the EGF segments. These three proteins are secreted
by transfected BHK cells and assembled into normal hexa-
brachion molecules (Aukhil et al., 1993). Finally, we have
produced two bacterial expression proteins for FN domains. 
Of particular interest is the domain TNfn3, which has an
RGD sequence in human and chicken TN, and whose struc-
ture has recently been solved to atomic resolution (Leahy
et al., 1992). In our initial studies we found that fibroblasts
did not adhere to TNfn3 or to larger segments containing
it. However, Prieto et al. (1992) demonstrated adhesion of
fibroblasts and other cells to fusion proteins containing
TNfn3, using an assay that was perhaps more sensitive than
ours. 
A key observation leading to our present analysis was
that endothelial cells adhere very strongly to TNfn3. As
well, endothelial cells adhere much more strongly than
fibroblasts to FNfn10, the RGD-containing domain from
FN. Because endothelial cells exhibited the strongest adhe-
sion to several proteins, and because TN is frequently asso-
ciated with blood vessels (Erickson and Bourdon, 1989),
we explored in detail adhesion of endothelial cells to
domains of TN and FN, and compared them to several other
cell lines that have weaker or no adhesion. Finally, we have
new experimental work that addresses the controversy over
whether intact TN can act as a cell adhesion substratum.
The adhesion activity depends on the nature of the sub-
P. Joshi and others
Fig. 1. Diagram of the domain
structure of the TN subunit, and the
expression proteins used in the
present study. In addition to the TN
proteins, two expression proteins for
FN used in this study are indicated.
(From Aukhil et al., 1993.)
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stratum (plastic vs nitrocellulose) and the length of time the
TN is incubated on the substratum. 
MATERIALS AND METHODS
Cells and reagents
Non-transformed fetal bovine aortic endothelial cells (AG7680),
and a transformed line derived from them (GM7373) (Grinspan
et al., 1983; Maier et al., 1990) were obtained from Coriell Insti-
tute for Medical Research, Camden, NJ. Endothelial cells from
mouse brain, heart and thorax were provided by Dr Robert Auer-
bach, Department of Zoology, University of Wisconsin, Madison.
Cells were cultured in DMEM-H (Dulbecco’s Modified Eagle’s
Medium, high glucose) with 10% fetal calf serum. NRK cells were
obtained from the ATCC, and the hamster fibroblasts NIL.8M
were obtained from Dr Richard Hynes, MIT. Anti-αvβ3 and anti-
α5β1 antisera were purchased from Telios Pharmaceuticals, Inc.,
San Diego, CA. Native FN was purified from human plasma by
gelatin-agarose affinity chromatography, and native TN was puri-
fied from conditioned medium of U-251 MG glioma cells by gel
filtration and anion exchange chromatography (Aukhil et al.,
1990). 
Bacterial expression proteins for defined domains of TN and
FN were produced and purified as described by Aukhil et al.
(1993). Tenascin and the TNfn3 domain were iodinated by the
Chloramine T method (Greenwood et al., 1963) to a specific
activity of 0.3-1 mCi per µg of protein. The integrity of the labeled
protein was determined by SDS-PAGE followed by autoradio-
graphy.
Cell adhesion assay
The assay was carried out as described by Lightner and Erickson
(1990) and Aukhil et al. (1993). Falcon 3912 microtitre plates,
which are 96-well polyvinylchloride plastic not treated for tissue
culture, were used for quantitative assays. For experiments shown
in Figs 2-8, substrata were coated with protein by adding 100 µl
protein solution in phosphate buffered saline (PBS) at 37°C for
60 min. Wells were emptied, washed twice with PBS, and free
sites on plastic were blocked by adding 1 mg/ml heat-denatured
BSA for 1 hour, followed by a PBS wash. (For the experiments
in Figs 9-10 the substratum proteins were coated in 20 mM Tris-
HCl, pH 7.4, 150 mM NaCl, 1 mM CaCl2, 1 mM MgCl2 at the
temperatures and times indicted, and then blocked with 5% non-
fat dried milk. Also in these experiments, plastic substrata were
compared with plastic over-coated with nitrocellulose, prepared as
follows: 20 cm2 nitrocellulose paper (Bio-Rad) was dissolved in
50 ml of methanol, 20 µl of nitrocellulose solution was added to
each well and dried under the laminar-flow hood.) Each well was
loaded with 100 µl PBS (sometimes containing an inhibitor such
as RGD peptide) and 35,000 to 50,000 cells in 100 µl DMEM
medium. Prior to this assay the cells had been removed from their
substratum by mild treatment with trypsin EDTA. The plates were
incubated for 60 min at 37°C in an atmosphere of 5% CO2,
unbound cells were removed by gentle pipetting, wells were
washed twice with PBS and cells were fixed with 3%
paraformaldehyde. 
Attached cells were quantitated by staining with 1% Toluidine
blue and lysing the cells with 2% SDS. The intensity of the color
was measured at 595 nm. Readings in wells precoated with BSA
(typically A595 ~0.04) were considered as blank and subtracted
from each value. Three duplicate wells were averaged for each
point tested. The standard deviation of the three points was typi-
cally about 10% of the mean. Although this staining procedure
does not permit an easy determination of the fraction of cells
bound, we have previously determined (Lotz et al., 1989) that cell
binding is saturated at 10 µg/ml FN, with >80% of the cells bound.
The A595 corresponding to this saturated binding of cells to FN
varied from 0.5 to 0.6 in most experiments, so A595 values of 0.3
or 0.1 indicate 50% and 20% of added cells bound. 
RESULTS
Endothelial cell adhesion to recombinant TN and
fibronectin domains 
We tested the cell adhesion activity of all 12 of our bac-
terial expression proteins and the three mammalian TN con-
structs, as well as purified native TN and fibronectin. Most
of our work used the transformed endothelial cell line
GM7373, but identical results were obtained with each of
the endothelial cell lines tested. Table 1 summarizes the
adhesion results for the GM7373 cells, their untransformed
parent line AG7860, and three other cell types. The adhe-
sion responses fell into three distinctly different categories:
(1) adhesion and spreading; (2) adhesion but no spreading
(cells remain round); and (3) no adhesion (Fig. 2 and Table
1).
An important preliminary discovery in these experiments
was that endothelial cells adhere much more avidly than
other cell types tested. This was particularly evident in
adhesion to the single FN-III domains FNfn10 and TNfn3.
All endothelial cells tested adhered to these domains,
Table 1. Cell adhesion to TN and FN expression proteins
Cell type TNfn3 TNfn1-5 TNfnALL TNfbg FNfn10 FNfn7-10
GM7373 endothelial Ad S Ad R Ad R Ad R Ad R Ad S
AG7860 endothelial Ad S Ad R Ad R Ad R Ad R Ad S
NRK epithelial Ad R Ad R Ad R
RES fibroblasts N Ad N Ad N Ad Ad R N Ad Ad S
NIL fibroblasts N Ad N Ad Ad R N Ad Ad S
Cell adhesion to the different substrata was classified into three categories: adherent and spread (Ad S), adherent and round (Ad R) and non-adherent (N
Ad). These results are for proteins coated on plastic for 60 min. The expression proteins TNfnA-D, TNfn6-8 and HxB.egf gave no adhesion of any cell
type tested. 
Because our assay showed no adhesion of fibroblasts to domains containing TNfn3, while Prieto et al. (1992) did observe adhesion of fibroblasts to
similar domains, we sent samples of our proteins to Prieto and Crossin to test in their assay. Proteins were coated at higher concentration than we use, i.e.
50-100 µg/ml. Consistent with our results, they observed no adhesion to TNfnA-D or to TNfn6-8, but substantial adhesion to TNfbg. In addition, they
observed adhesion of U251 MG glioma cells and 3T3 fibroblasts to TNfn3, TNfn1-5 and TNfn1-8. Apparently their assay is sufficiently sensitive to
demonstrate adhesion of fibroblasts to segments containing TNfn3, which are negative in our assay (A. L. Prieto and K. L. Crossin, personal
communication.)
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whereas fibroblasts did not. It is well established from pre-
vious studies that fibroblasts adhere and spread on FNfn7-
10, but adhere very weakly or not at all to the single domain
FNfn10 (Kimizuka et al., 1991; Aota et al., 1991; Aukhil
et al., 1993). In addition to the two lines of fetal bovine
aortic endothelial cells listed in Table 1, endothelial cell
lines 14077-(P9) from mouse heart, 1841-(P9) from mouse
brain, and 1-C4 from mouse thoracic duct, all provided by
Dr R. Auerbach, University of Wisconsin, attached and
spread on TNfn3. All of these endothelial cells also attached
but remained rounded on TNfbg. 
The only TN expression proteins that promoted cell adhe-
sion were the domains TNfn3 (and larger segments that
contain it) and TNfbg. No adhesion of any cell type was
observed to TNfnA-D (the alternatively spliced segment),
to TNfn6-8 (the last three FN-III domains), or to the mam-
malian expression protein HxB.egf, which comprises the
central knob and the 14 EGF domains. Remarkably, prepa-
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Fig. 2. Attachment and spreading of endothelial GM7373 cells on substrata coated with recombinant FN or TN fragments. For these
microscope examinations, Nunc Lab-Tek polystyrene chamber slides were coated with native FN (5 µg/ml), FNfn10 (10 µg/ml), FNfn7-
10 (5 µg/ml), native TN (purified from U-251 MG cell cultures, 25 µg/ml), TNfn3 (5 µg/ml), TNfn1-5 (10 µg/ml), TNfnALL (10 µg/ml),
TNfn1-8 (10 µg/ml), and TNfbg (25 µg/ml). GM7373 endothelial cells were harvested with trypsin-EDTA and allowed to attach and
spread on the substratum for 1 hour before fixation and photography. The fields shown here were selected to show a large number of cells
of representative morphology, and do not always reflect the number of cells bound, e.g. TNfnALL gave the weakest adhesion in the
quantitative assay. Quantitation of adhesion is given in Fig. 3. Bar, 100 µm.
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rations of native tenascin were completely negative for cell
attachment in this assay condition (native TN in Fig. 2).
Adhesion activity of native TN was later revealed by coat-
ing the protein on nitrocellulose or plastic for much longer
times than the 60 min used for our routine assays (Figs 9-
10).
Endothelial cell adhesion to TNfn3 is partially
blocked by adjacent TNfn2 and is inhibited by
RGD peptides and by antiserum to v 3
Fig. 3 shows the concentration dependence of adhesion to
TNfn3 and to larger segments containing this domain. The
single domain TNfn3 had the highest activity, and there was
a clear trend toward reduced adhesion as more domains
were added. The larger segments showed progressively less
adhesion at a given coating concentration (e.g. 1-2 µg/ml),
and the maximal adhesion obtained at any concentration
was also reduced. Adhesion to the larger segments actually
fell off at higher concentrations. This is seen in Fig. 3 for
TNfn1-5, and was also observed for TNfn1-8 and TNfn-
ALL, which gave reduced adhesion at 20 µg/ml and no
adhesion at all when coated at 100 µg/ml (data not shown).
The reduced adhesion activity of the larger fragments may
be due to the increased steric blocking by the non-adhesive
domains. 
A second and very striking aspect of reduced adhesion
was that the cells avidly spread on TNfn3, whereas on the
larger domains they remained rounded (Fig. 2). Substrata
giving the rounded phenotype did so at all coating con-
centrations, i.e. there was no indication that cell spreading
could be obtained at higher substratum densities. It seems
that TNfn3 has a very strong adhesion activity, sufficient
to promote complete cell spreading, when presented on the
substratum as an isolated domain, but this activity is
severely reduced when the domain is incorporated into a
larger segment. The explanation for this aspect of reduced
adhesion was suggested by the X-ray crystal structure of
Tnfn3.
The crystal structure showed that the RGD sequence in
TNfn3 is on a tight beta turn, exposed on the surface of the
domain (Leahy et al., 1992). Although the RGD sequence
is toward the C terminus of the linear sequence, in the 3-
D structure it is seen to be very close to the N terminus.
This suggested that the adjacent domain TNfn2 might par-
tially block the RGD. To test this hypothesis we synthe-
sized the segments TNfn1-3 and TNfn3-5 (Fig. 1). As seen
in Figs 4 and 5, the adhesive activity of these segments is
consistent with this prediction. Cells attached and spread
on TNfn3 and TNfn3-5, both of which have the RGD
exposed at the N terminus. Cell attachment to TNfn1-3
required higher substratum concentrations, and the cells
remain rounded. The adhesion activity of TNfn1-3 was
almost identical to that of TNfn1-5. 
Since TNfn3 (from human and chicken) contains an RGD
sequence, we tested whether RGD peptides would inhibit
adhesion. Fig. 6 shows that adhesion to TNfn3 and to larger
segments containing it is extremely sensitive to soluble
RGD peptide. Adhesion to TNfn3 and TNfn3-5, on which
cells spread, was inhibited 70% by 2.5 µg/ml of soluble
GRGDSP. Adhesion to TNfn1-3 and to FNfn10 was inhib-
ited at GRGDSP concentrations as low as 0.2-0.5 µg/ml.
The control peptide GRGESP had no effect at 25 µg/ml.
Adhesion to these domains is thus much more sensitive to
soluble RGD peptides than is adhesion to intact fibronectin,
which requires 350-1,000 µg/ml for ~70% inhibition
(Pierschbacher and Ruoslahti, 1984, and our unpublished
data), or to vitronectin, which is inhibited by 35-100 µg/ml
RGD (Pierschbacher and Ruoslahti, 1987). 
The sensitivity to RGD peptides strongly suggests that
the adhesion is mediated by an integrin receptor. An inte-
grin interaction was also suggested by the cation require-
ment for adhesion: EDTA or EGTA (2.5 mM) completely
abolished cell attachment to TNfn3, TNfn1-5 and FNfn10
(data not shown). 
To confirm the involvement of integrins and to identify
the specific molecules, we obtained polyclonal antisera
against αvβ3 and α5β1 integrins, which block the activity
of the specific integrin (see Massia and Hubbell, 1991, for
a previous use of these antisera). Cell attachment to TNfn3
was inhibited by anti-αvβ3 antiserum (Fig. 7). This anti-
serum also inhibited cell attachment to TNfn1-5 and to
FNfn10. Anti-α5β1 antiserum gave no inhibition on any
substrata. These results suggest that endothelial cell adhe-
sion to TNfn3 and to FNfn10 is mediated by the integrin
αvβ3.
Endothelial cells adhere to TNfbg 
Only one other TN domain, TNfbg, showed cell adhesion
activity for endothelial cells. In a previous study we
observed that fibroblasts attached to TNfbg, and that adhe-
sion was mediated by a cell surface proteoglycan, not an
integrin (Aukhil et al., 1993). Thus fibroblast cell attach-
ment was inhibited by treating the substratum with heparin
(which binds to TNfbg), or by treating the cells with hepari-
nase (which cleaves cell surface heparan sulfate) or with
chlorate ions (which inhibit sulfation of proteoglycans). We
Substratum concentrations (µg/ml)
Fig. 3. Attachment of GM7373 cells to TNfn3 and to three larger
expression proteins containing this domain. The concentration of
the protein used to coat the plastic substratum is shown on the
abscissa. Results are the mean of triplicate observations in an
experiment. Similar results were obtained when the experiment
was repeated twice. BSA served as a negative control, and it’s
value (A595 0.035) has been subtracted from all points. 
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expected the adhesion of endothelial cells to TNfbg also to
be mediated by proteoglycans. However, several experi-
ments (data not shown) suggest that endothelial cell adhe-
sion to TNfbg is mediated by integrins, with little or no
contribution from proteoglycans. (1) Adhesion was com-
pletely eliminated by adding 2.5 mM EDTA or EGTA to
the medium. These chelators had no effect on fibroblast
adhesion to TNfbg, but are known to inhibit integrin-medi-
ated adhesion (Hynes, 1992). (2) Adhesion of endothelial
cells to TNfbg was not inhibited by heparin, or by treating
the cell cultures with chlorate. (3) Adhesion was inhibited
by the peptide GRGDSP (Fig. 8) at peptide concentrations
of 25-50 µg/ml, similar to the concentration that inhibits
cell adhesion to vitronectin. Endothelial cell adhesion to
TNfbg was not inhibited by the antisera to either the αvβ3
or the α5β1 integrins. 
A search for anti-adhesion domains
Since two domains of TN gave adhesion of endothelial cells
when tested as isolated domains, we wanted to address the
question: why do endothelial cells not adhere to native TN?
One possibility was that an anti-adhesion domain might
overwhelm the adhesion activity. Our interest focused on
two segments: first, the segment TNfnA-D, which we have
found to provoke dismantling of focal adhesions when
added to endothelial cells spread on fibronectin (Murphy-
Ullrich et al., 1991); second, the segment TNfn6-8, which
has been identified in two studies as inhibiting the adhe-
sion and/or spreading of fibroblasts on FN (Chiquet et al.,
1991; Prieto et al., 1992). 
We first addressed this question by testing our mam-
malian expression proteins, HxB.L and HxB.S, corre-
sponding to the two splice variants of native TN. Each of
these is assembled by the cells and secreted as intact hexa-
brachions. Since HxB.S is missing the alternatively spliced
segment (TNfnA-D), cells would be expected to adhere to
it if this segment were responsible for a dominant anti-adhe-
sion effect. However, we found that endothelial cells did
not adhere to HxB.L, HxB.S (or to HxB.egf, a truncated
hexabrachion containing only the EGF domains) at any sub-
stratum coating concentrations tested, up to 100 µg/ml.
(Note that these experiments were all done by coating the
proteins for 60 min on plastic; cf. Figs 9-10, below, for
conditions giving positive adhesion to native TN.) Thus the
alternatively spliced segment does not seem to be respon-
sible for the lack of cell adhesion to native TN. 
We next made an equimolar mixture of bacterial
expression proteins TNfn1-5, TNfnA-D, TNfn6-8 and
TNfbg, and the mammalian protein HxB.egf. This mixture
should be equivalent to a complete TN subunit. This mix-
ture was used to coat plastic at concentrations of 20, 100
and 200 nM (total protein concentration 5-50 µg/ml) and
tested for cell adhesion. GM7373 cells adhered to this sub-
stratum at all three concentrations, the cells remaining
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Fig. 4. Attachment and spreading of GM7373
cells on TNfn3, TNfn1-3 and TNfn3-5
substrata. Cells attach and spread on TNfn3
and TNfn3-5 (coated at 5 µg/ml), in which the
N terminus of TNfn3 is exposed, whereas
they remain rounded on TNfn1-3 (coated at
10 µg/ml), in which the N terminus of TNfn3
(and the RGD sequence) is partially blocked
by the adjacent TNfn2 (Leahy et al., 1992).
Bar, 100 µm.
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rounded as on the separate segments TNfn1-5 and TNfbg.
Thus the complete tenascin subunit can support adhesion
when coated onto the plastic substratum as a mixture of
smaller pieces. 
Finally, we tested directly whether TNfnA-D or TNfn6-
8 could inhibit adhesion to any defined adhesion substra-
tum. Native FN, TNfn3 and TNfbg were separately coated
on plastic and tested for cell adhesion in the presence of
TNfnA-D or TNfn6-8, added with the cells as soluble mol-
ecules. TNfnA-D had no effect on adhesion to any sub-
stratum at concentrations up to 500 µg/ml. TNfn6-8 gave
mixed results: in some experiments it inhibited cell adhe-
sion to FN by 30-50% when added with cells at 20-500
µg/ml, but in other experiments under apparently identical
conditions it gave no inhibition at all. Even in experiments
showing inhibition, the concentration dependence was fre-
quently erratic. We therefore could not demonstrate a repro-
ducible inhibitory effect of TNfn6-8, but further work is
clearly indicated in view of the substantial inhibitions
reported by Chiquet et al. (1991) and Prieto et al. (1992). 
We also tested whether the adhesion domains of tenascin
might be revealed by breaking the hexabrachion structure
into single arms. We treated TN with 2 mM DTT for 30
min before coating on plastic, conditions that we have found
sufficient to reduce the disulfide bonds in the central nodule
and convert the hexabrachion into single subunits (Erick-
son and Briscoe, 1993). Substrata of reduced TN coated on
plastic at concentrations up to 100 µg/ml were completely
negative for adhesion activity in this assay. If there is a
structural feature that blocks cell adhesion it appears to be
inherent to each arm of the hexabrachion. 
Cell adhesion to TN and recombinant domains
depends on the substratum (plastic vs
nitrocellulose) and on the coating time
Because nitrocellulose is known to bind proteins tightly and
in a conformation suitable for binding antibodies and other
ligands, we compared cell adhesion to proteins coated either
on plastic or nitrocellulose. Fig. 9 shows that the chemical
nature of the supporting substratum has a dramatic effect
on adhesion activity. When the proteins were coated on
Substratum concentrations (µg/ml)
Fig. 5. Quantitative assay of adhesion to TNfn3, TNfn1-3 and
TNfn3-5, as a function of substratum-coating concentration. 
Anti-αvβ3
Anti-α5β1
Fig. 7. Effects of integrin-specific antisera on GM7373 cell
attachment to TNfn3 (open circles) or FNfn10 (filled circles). The
coating concentrations of TNfn3 and FNfn10 were 1 and 3.6
µg/ml, respectively. (A) shows the effect of different dilutions of
anti-αvβ3, and (B) shows anti-α5β1. 
Fig. 6. Soluble GRGDSP inhibits cell attachment to the RGD-
containing domains from TN and FN. The substratum-coating
concentrations were 1 µg/ml for TNfn3; 2.5 µg/ml for TNfn3-5;
20 µg/ml for TNfn1-3; and 5 µg/ml for FNfn10. 
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plastic at 4°C for 12 hours, TNfn3 (20 µg/ml) gave strong
adhesion, TNfbg (50 µg/ml) a weaker adhesion, while
native TN (100 µg/ml) gave a weaker but still significant
adhesion. The very weak adhesion to TNfnA-D and TNfn6-
8 was not seen in most experiments. Cells spread on TNfn3
and FN, but remained rounded on TNfbg. On nitrocellu-
lose, TNfn3 again gave strong adhesion, but TNfbg had no
activity. Most remarkable, native TN on nitrocellulose
demonstrated strong adhesion activity. This cell adhesion
activity was not due to contamination by fibronectin or
other adhesive proteins, since it could be blocked by a poly-
clonal antiserum to TN. Interestingly, TNfn3 on nitrocellu-
lose was less active than TNfn3 on plastic. Furthermore,
cell spreading was greatly reduced when TNfn3 was coated
on nitrocellulose, relative to the very pronounced spread-
ing on TNfn3 on plastic. Cells adhering to native TN
remained rounded on both plastic and nitrocellulose.
Fibronectin, as a positive control, supported strong cell
adhesion and spreading on both plastic and nitrocellulose. 
The cell adhesion activity of native TN required a
remarkably long incubation time for coating the substra-
tum. Fig. 10 shows the adhesion to native TN, TNfn3 and
FN coated on plastic and nitrocellulose at 4°C for different
times. While the cell adhesion activity of FN and TNfn3
reached a maximum after 1-3 hours coating time, the
activity of native TN increased much more slowly out to
24 hours, the last time tested. At all time points tested, TN
gave higher adhesion on nitrocellulose than on plastic. In
contrast, FN had the same activity on both substrata, while
TNfn3 had lower adhesion on nitrocellulose and, as noted
above, cells only partially spread on this substratum. 
One possibility for the differential effects was that adhe-
sion activity might reflect different amounts of protein
bound to the substrata. We therefore compared the amount
of TN and TNfn3 domain bound to plastic and nitrocellu-
lose by using radiolabeled proteins. As expected, both TN
and TNfn3 bound more abundantly to nitrocellulose than
to plastic. Thus, at least for TNfn3, adhesion is not simply
correlated with the amount of protein bound: adhesion is
weaker on nitrocellulose even though more protein is
bound. For native TN on nitrocellulose the time course of
cell adhesion correlated reasonably well with that of pro-
tein binding. There was a 70% increase in both protein
bound and adhesion at 24 hours compared to 6 hours. This
correlation did not hold, however, for TN on plastic. Here
protein binding was almost complete at 3-6 hours, increas-
ing only about 20% from 6 to 24 hours. In contrast, cell
adhesion doubled from 6 to 24 hours. These results suggest
that the majority of TN molecules that bound to plastic in
the first 3-6 hours of incubation are not active in cell adhe-
sion, while a smaller fraction that bound over the next 18
hours are active. 
We also tested whether the GRGDSP peptide would
inhibit cell adhesion to native TN. The peptide GRGDSP
completely inhibited adhesion of cells to TN coated on
either plastic or nitrocellulose at a concentration of 20-50
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Fig. 8. Inhibition of GM7373 cell adhesion to TNfbg by GRGDSP
peptide. The substratum coating concentration was 20 µg/ml. 
Fig. 9. Attachment of endothelial cells GM7373 on plastic (A)
and nitrocellulose (B) coated with TN, TN fragments or FN. Each
substratum was coated with native TN (100 µg/ml), TNfnA-D (50
µg/ml), TNfn3 (20 µg/ml), TNfn6-8 (50 µg/ml), TNfbg (50
µg/ml) or FN (50 µg/ml) for 12 hours at 4˚C. GM7373 cells were
harvested with trypsin-EDTA, washed, and allowed to attach on
the substratum for 1 hour at 37˚C. Attached cells were fixed,
stained with toluidine blue, and read at 595 nm.
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µg/ml (Fig. 10D). The control peptide GRGESP had no
effect on adhesion at concentrations up to 500 µg/ml. The
GRGDSP peptide thus inhibits adhesion to native TN at
low concentrations, similar to those effective on TNfn3 and
TNfbg, and at least 10 times lower than the concentrations
needed to inhibit adhesion to FN. 
DISCUSSION
Our initial study of rat embryo skin fibroblasts (Aukhil et
al., 1993), identified a single cell adhesion domain in TN,
TNfbg. Prieto et al. (1992) observed adhesion of several
cell types to their fusion proteins containing TNfn3, and
they have also demonstrated adhesion of fibroblasts to our
expression proteins containing TNfn3 (see note to Table 1).
We conclude that their assay is more sensitive than ours in
detecting the weak adhesion of fibroblasts to TNfn3. 
We were surprised that fibroblasts did not adhere to either
TNfn3 or FNfn10, because each of these domains contains
the RGD sequence. We therefore expanded our study from
fibroblasts to a variety of other cell types, and discovered
that endothelial cells adhere strongly to both of these
domains, as well as to larger segments that contain them.
The vigorous adhesion of endothelial cells makes them an
ideal candidate for identifying cell adhesion substrata. In
the present study endothelial cells have been especially
valuable in demonstrating the two cell adhesion domains of
TN. 
The first site, which mediates adhesion of fibroblasts
(Aukhil et al., 1993) and all other cells tested, is in the ter-
minal knob domain, TNfbg. This site is probably the one
that Spring et al. (1989) attributed to the adjacent TNfn7-
8, and it has been demonstrated independently by Prieto et
al. (1992). In this latter study, as in ours, cells remain
rounded on TNfbg. Surprisingly, the mechanism of ad-
hesion to TNfbg seems to vary with cell type. Fibroblasts
Fig. 10. (A) Attachment of GM7373 cells on plastic and nitrocellulose coated with native TN, native FN and TNfn3, as a function of the
time the proteins were incubated with the substratum. Proteins were coated at 20 µg/ml and 4˚C. (B and C) Determination of the amount
of substratum-bound TN (B) and TNfn3 (C), as a function of incubation time. Radiolabeled TN and TNfn3 (20 µg/ml each) were
incubated with plastic and nitrocellulose for various time at 4˚C and radioactivity of substratum-bound material was determined. (D)
GRGDSP peptide inhibits endothelial cell adhesion to native TN. Substrata were coated with TN for 24 hours at 4˚C. Control peptide
GRGESP had no effect on adhesion at a concentration of 500 µg/ml.
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adhere via a heparin sulfate proteoglycan (Aukhil et al.,
1993), while the present study suggests that endothelial
cells may adhere via an integrin. The inhibition of ad-
hesion by RGD peptides is remarkable because TNfbg does
not contain any RGD sequence, but this situation is not
unique. The matrix Gla protein also contains no RGD
sequence, but cell adhesion is strongly inhibited by 3 µg/ml
of soluble RGD peptide (Loeser and Wallin, 1992). 
The second cell adhesion site is TNfn3, which contains
an RGD sequence in human and chick TN. Endothelial cells
adhere strongly to and spread on TNfn3 and on TNfn3-5.
All segments containing TNfn3 and having TNfn2 attached
at the N terminus gave weaker adhesion and the cells
remained rounded. The explanation for the reduced adhe-
sion was suggested by the X-ray crystal structure (Leahy
et al., 1992), which showed the RGD segment to be near
the N terminus of TNfn3, where it can be partially blocked
by TNfn2. Adhesion to TNfn3, and also to the single FN
domain FNfn10, appears to be mediated by the αvβ3 inte-
grin, because it is blocked by an antibody to that integrin,
requires divalent cations, and is exquisitely sensitive to sol-
uble RGD peptides. 
The activities of TNfn6-8 remain controversial. Two lab-
oratories have reported anti-adhesion activity for these
domains (Chiquet et al., 1991; Prieto et al., 1992), but in
our experiments TNfn6-8 gave equivocal results. We some-
times observed an inhibition of cell adhesion, but in most
experiments the effect was not reproduced. Prieto et al.
(1992) also reported that TNfn7-8 would support cell adhe-
sion if the cells were treated with trypsin before the assay.
Our cells are routinely harvested with trypsin before the
assay and we found no adhesion to TNfn6-8. 
Why do endothelial cells adhere more strongly than
fibroblasts to the RGD-containing domains? One possibil-
ity is that endothelial cells may have substantially more
αvβ3 integrin than fibroblasts. αvβ3 and α5β1 both con-
tribute to adhesion of microvascular endothelial cells to
intact FN (Cheng et al., 1991), but HT-1080 fibrosarcoma
cells use only α5β1 to adhere to FN and to expression pro-
teins similar to our FNfn7-10 (Aota et al., 1991). 
We do not understand why adhesion to TNfn3 is stronger
than to FNfn10. Both of these single FN-III domains con-
tain an RGD sequence on a tight turn between the F and
G beta strands (Leahy et al., 1992; Main et al., 1992). If
anything, we would have expected stronger adhesion to
FNfn10, in which the RGD loop extends outward about 7
Å further than in TNfn3. The strong adhesion to TNfn3
might involve other patches on the surface of this domain,
but we have not initiated tests that might reveal the mech-
anism. 
What is the biological significance of endothelial cell
adhesion to TNfn3 and TNfbg? Two observations suggest
that adhesion to TNfn3 may not be biologically important.
First, this adhesion is dramatically reduced in the native
molecule or in any protein that has TNfn2 linked to TNfn3.
One might postulate a specific proteolytic cleavage, or a
bending of the hexabrachion arm, that could expose the
stronger adhesion site, but there is no evidence for such
processing. Second, the RGD sequence that is found in
human and chick TN is replaced by RVD in mouse (Weller
et al., 1991; Saga et al., 1991), RAD in pig (Nishi et al.,
1991), and RGL in newt (Onda et al., 1991) TN. Both the
cryptic location of the RGD in the intact TN molecule, and
the species variation of the RGD sequence, suggest that this
site may not be functional in cell adhesion. 
Cell adhesion to TNfbg seems more likely to be biolog-
ically important. This site at the tip of each arm of the hexa-
brachion is ideally exposed for binding to cell surfaces, and
indeed almost all cells tested bind to it (Prieto et al., 1992;
Aukhil et al., 1993, and this paper). Although the cell adhe-
sion to TNfbg is weaker than to FN or vitronectin, the large
size and multivalent structure of the hexabrachion would
make it an ideal bridge between cells. Alternatively, the
physiological role of cells binding TNfbg might be some-
thing other than cell adhesion. The receptors for TNfbg
might respond directly to the ligand binding by a signalling
mechanism, or the binding might enhance interaction of TN
with other receptors. 
The experiments reported here may resolve the long con-
troversy over the cell adhesion activity of native TN. Pre-
vious studies in our laboratory and several others reported
no cell adhesion to TN-coated plastic substrata (Erickson
and Taylor, 1987; Mackie et al., 1987; Lotz et al., 1989;
Lightner and Erickson, 1990; Aukhil et al., 1990; Saginati
et al., 1992), whereas other groups have reported a weak
adhesion of cells with a rounded morphology (Friedlander
et al., 1988; Bourdon and Ruoslahti, 1989; Chiquet-Ehris-
mann et al., 1988; Spring et al., 1989; Nörenberg et al.,
1992; Prieto et al., 1992). Our present experiments suggest
that the adhesion activity depends on how the substratum
is prepared. If native TN is coated on plastic for 1-2 hours,
the standard conditions for our assays over the years, it has
no adhesion activity. We have now found two conditions
that reveal a cell adhesion activity of TN: (1) coat the pro-
tein on plastic as separate domains or as a mixture of
expression proteins, corresponding to tenascin subunits cut
into pieces; or (2) coat the plastic with native TN for 12-
24 hours, instead of the 1-2 hours that is sufficient for most
other adhesion proteins (coating on nitrocellulose produces
a stronger adhesion than on plastic). The mechanism for
exposing or concealing the adhesion site(s) is not clear, but
it may involve the orientation of the molecules when they
are coated under different conditions. For example, it may
be important that the terminal knobs, which we believe are
the active adhesion domains in native TN, are pointing up
toward the cells rather than bound to the plastic. 
The results of the study by Sriramarao et al. (1993) agree
with most of our findings and complements our observa-
tions in important aspects. They observed adhesion of endo-
thelial cells to native TN coated on plastic (note that they
coated the plastic overnight, 12-14 hours) and identified two
integrins that are involved. Both their results and ours show
that αvβ3 binds to the TN domain TNfn3. The second
TN–binding integrin that Sriramarao et al. discovered, α2β1,
bound to an unknown domain of TN. In our work we con-
cluded that the TN domain TNfbg bound an unknown inte-
grin. We suggest that these results complement each other,
and α2β1 may be the integrin that binds TNfbg. Moreover,
the peptide and antibody inhibition studies suggest that
α2β1 integrin binding to TNfbg may be the primary mech-
anism of adhesion of endothelial cells to native TN. The
peptide GRGDSP inhibited adhesion to both TNfbg and
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native TN (Figs 8, 10D; and Bourdon and Rouslahti, 1989),
whereas the SRRGDMS peptide from TNfn3 only partially
inhibited adhesion to native TN. Antibodies against α2β1
blocked adhesion to native TN much more effectively than
antibodies against αvβ3. As suggested above, the binding
of αvβ3 to TNfn3 may not be a biologically significant
mechanism, but binding of α2β1 to TNfbg probably plays
a role in binding native TN to endothelial cells. 
Finally, we must recognize that the activities observed in
these cell culture assays are apparently not vital for normal
animal development, since complete deletion of TN in a
mouse produced no detectable phenotype (Saga et al.,
1992). TN is apparently not an essential component of the
endothelium, in spite of the fact that it is localized around
many blood vessels and mediates adhesion of endothelial
cells. It is premature, however, to conclude that TN has no
role in blood vessel structure. It is possible that TN con-
tributes in a non-vital but supportive capacity to angiogen-
esis, to maintain the structure of formed blood vessels, or
to modulate the function of endothelial and smooth muscle
cells. The roles of TN may be subtle, contributing to sur-
vival under conditions of stress, yet not producing a gross
phenotype that would be obvious from casual observation
of mice in a laboratory environment. Biochemical and cell
culture experiments may provide clues as to where to look
for subtle roles in living animals. The present work suggests
that the vasculature in the tenascin knockout mice should
be examined closely for defects, perhaps under conditions
of stress. 
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Note added in proof
We have recently developed three polyclonal antibodies to
separate recombinant proteins that allow us to probe the
domains that promote adhesion to the native TN substra-
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tum. Antibodies to TNfn1-5 or TNfnA-D, applied to the
TN substratum before the cells, inhibited adhesion of endo-
thelial cells only slightly, while an antibody to TNfn6-8
plus TNfbg (the two proteins were combined for this
immunization) inhibited adhesion 80%. Thus TNfbg
appears to be the major cell adhesion site in substrata of
native TN.
